Identification of the DC-SIGN-interactive domains on the envelope glycoprotein of HIV-1 CRF07-BC

AIDS Research and Human Retroviruses

Volumn 27, Issue 8, 2011, Pages 831-839

  Liao, Che Feng ^a   Wang, Sheng Fan ^a,b   Lin, Yu Ting ^a   Ho, David D ^c   Chen, Yi Ming Arthur ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b ACADEMIA SINICA   (Taiwan)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD209 ANTIGEN; GLYCAN; GLYCOPROTEIN GP 120; POLYCLONAL ANTIBODY; POLYCLONAL ANTIBODY R70; POLYCLONAL ANTIBODY R72; POLYCLONAL ANTIBODY R74; POLYCLONAL ANTIBODY R77; RABBIT ANTISERUM; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ANTIBODY COMBINING SITE; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 CIRCULATING RECOMBINANT FORM 07 BC; IN VITRO STUDY; INTRAVENOUS DRUG ABUSE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN INTERACTION; SITE DIRECTED MUTAGENESIS; VIRUS ATTACHMENT; VIRUS RECOMBINANT; VIRUS STRAIN;

ANIMALS; ANTIBODIES, BLOCKING; BINDING SITES; CELL ADHESION MOLECULES; CELL LINE; CHINA; DENDRITIC CELLS; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; IMMUNE SERA; IMMUNOASSAY; LECTINS, C-TYPE; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; MUTATION; PLASMIDS; POLYSACCHARIDES; PROTEIN BINDING; RABBITS; RECEPTORS, CELL SURFACE; SEQUENCE ANALYSIS, DNA; TAIWAN; TRANSFECTION; VIRUS INTERNALIZATION;

EID: 80051508433     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2010.0215     Document Type: Article

References (36)

1. Soilleux EJ, Morris LS, Leslie G, et al.: Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J Leukoc Biol 2002;71:445-457.
2. Bleijs DA, Geijtenbeek TB, Figdor CG, and van Kooyk Y: DC-SIGN and LFA-1: A battle for ligand. Trends Immunol 2001;22:457-463. (Pubitemid 32709981)
3. Geijtenbeek TB, Torensma R, van Vliet SJ, et al.: Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000;100:575-585.
4. van Kooyk Y and Geijtenbeek TB: DC-SIGN: Escape mechanism for pathogens. Nat Rev Immunol 2003;3:697-709. (Pubitemid 41070811)
5. Geijtenbeek TB, Kwon DS, Torensma R, et al.: DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000;100:587-597.
6. Curtis BM, Scharnowske S, and Watson AJ: Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120. Proc Natl Acad Sci USA 1992;89:8356-8360.
7. Pohlmann S, Zhang J, Baribaud F, et al.: Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J Virol 2003;77:4070-4080. (Pubitemid 36350947)
8. Shih YP, Chen CY, Liu SJ, et al.: Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirus. J Virol 2006;80:10315-10324.
9. Wang SF, Huang JC, Lee YM, et al.: DC-SIGN mediates avian H5N1 influenza virus infection in cis and in trans. Biochem Biophys Res Commun 2008;373:561-566.
10. Wu L and KewalRamani VN: Dendritic-cell interactions with HIV: Infection and viral dissemination. Nat Rev Immunol 2006;6:859-868. (Pubitemid 44631654)
11. Lee B, Leslie G, Soilleux E, et al.: Cis Expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptor. J Virol 2001;75:12028-12038. (Pubitemid 33115875)
12. Burleigh L, Lozach PY, Schiffer C, et al.: Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells. J Virol 2006;80:2949-2957. (Pubitemid 43346390)
13. Zhang M, Gaschen B, Blay W, et al.: Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. Glycobiology 2004;14:1229-1246. (Pubitemid 39585357)
14. Korber B, Gaschen B, Yusim K, Thakallapally R, Kesmir C, and Detours V: Evolutionary and immunological implications of contemporary HIV-1 variation. Br Med Bull 2001;58:19-42. (Pubitemid 33070762)
15. Leonard CK, Spellman MW, Riddle L, Harris RJ, Thomas JN, and Gregory TJ: Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J Biol Chem 1990;265:10373-10382.
16. Hong PW, Nguyen S, Young S, Su SV, and Lee B: Identification of the optimal DC-SIGN binding site on human immunodeficiency virus type 1 gp120. J Virol 2007;81:8325-8336. (Pubitemid 47101517)
17. Zhou T, Chen Y, Hao L, and Zhang Y: DC-SIGN and immunoregulation. Cell Mol Immunol 2006;3:279-283.
18. Hong PW, Flummerfelt KB, de Parseval A, Gurney K, Elder JH, and Lee B: Human immunodeficiency virus envelope (gp120) binding to DC-SIGN and primary dendritic cells is carbohydrate dependent but does not involve 2G12 or cyanovirin binding sites: Implications for structural analyses of gp120-DC-SIGN binding. J Virol 2002;76:12855-12865. (Pubitemid 35386969)
19. Lin YT, Lan YC, Chen YJ, et al.: Molecular epidemiology of HIV-1 infection and full-length genomic analysis of circulating recombinant form 07-BC strains from injection drug users in Taiwan. J Infect Dis 2007;195:1283-1293.
20. Chen YM and Kuo SH: HIV-1 in Taiwan. Lancet 2007;369: 623-625.
21. Graham FL, Smiley J, Russell WC, and Nairn R: Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977;36:59-74.
22. Wu L, Martin TD, Carrington M, and KewalRamani VN: Raji B cells, misidentified as THP-1 cells, stimulate DCSIGN-mediated HIV transmission. Virology 2004;318:17-23. (Pubitemid 38234256)
23. Connor RI, Chen BK, Choe S, and Landau NR: Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 1995;206: 935-944.
24. Lozach PY, Amara A, Bartosch B, et al.: C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles. J Biol Chem 2004;279: 32035-32045. (Pubitemid 39014648)
25. Chen YM, Zhang XQ, Dahl CE, et al.: Delineation of typespecific regions on the envelope glycoproteins of human T cell leukemia viruses. J Immunol 1991;147:2368-2376.
26. Feinberg H, Mitchell DA, Drickamer K, and Weis WI: Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR. Science 2001;294:2163-2166. (Pubitemid 33150672)
27. Appelmelk BJ, van Die I, van Vliet SJ, Vandenbroucke-Grauls CM, Geijtenbeek TB, and van Kooyk Y: Cutting edge: Carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J Immunol 2003;170:1635-1639. (Pubitemid 36197376)
28. Guo Y, Feinberg H, Conroy E, et al.: Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR. Nat Struct Mol Biol 2004;11:591-598. (Pubitemid 38823524)
29. Naarding MA, Ludwig IS, Groot F, et al.: Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes. J Clin Invest 2005;115: 3256-3264. (Pubitemid 41567590)
30. van Liempt E, Bank CM, Mehta P, et al.: Specificity of DCSIGN for mannose-and fucose-containing glycans. FEBS Lett 2006;580:6123-6131. (Pubitemid 44666793)
31. Pokidysheva E, Zhang Y, Battisti AJ, et al.: Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN. Cell 2006;124:485-493. (Pubitemid 43199435)
32. Feinberg H, Guo Y, Mitchell DA, Drickamer K, and Weis WI: Extended neck regions stabilize tetramers of the receptors DC-SIGN and DC-SIGNR. J Biol Chem 2005;280: 1327-1335.
33. Sanders RW, Venturi M, Schiffner L, et al.: The mannosedependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. J Virol 2002;76:7293-7305.
34. Scanlan CN, Pantophlet R, Wormald MR, et al.: The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1?2 mannose residues on the outer face of gp120. J Virol 2002;76:7306-7321.
35. Trkola A, Purtscher M, Muster T, et al.: Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J Virol 1996;70:1100-1108. (Pubitemid 26029030)
36. Su SV, Hong P, Baik S, Negrete OA, Gurney KB, and Lee B: DC-SIGN binds to HIV-1 glycoprotein 120 in a distinct but overlapping fashion compared with ICAM-2 and ICAM-3. J Biol Chem 2004;279:19122-19132. (Pubitemid 38623343)